Body Health CalculatorA1C vs Fasting Glucose: Which Test Tells You More?
Fasting glucose shows your blood sugar at one moment after an overnight fast. A1c reflects average glucose over two to three months. Clinicians often use both for diagnosis and follow-up.
Last updated: September 2026
Markdown version for AI agents and developers
Summary
Hemoglobin A1c and fasting plasma glucose are the two most common blood tests for diabetes screening and monitoring. Fasting glucose captures one snapshot after eight or more hours without food. A1c integrates average glucose exposure over the lifespan of red blood cells, roughly two to three months.
They can disagree. Someone with elevated post-meal spikes may have a normal fasting glucose but a rising A1c. Another person with dawn phenomenon or stress hyperglycemia may see high fasting values while A1c stays near normal.
A1c vs fasting glucose comparison
| Fasting glucose | Hemoglobin A1c | |
|---|---|---|
| What it reflects | Blood sugar at one point in time | Average glucose over 2 to 3 months |
| Sample timing | 8+ hour fast, morning preferred | Any time, no fasting required |
| Units (US) | mg/dL | Percentage (%) |
| Diabetes threshold (ADA) | ≥126 mg/dL | ≥6.5% |
| Prediabetes range (ADA) | 100 to 125 mg/dL | 5.7 to 6.4% |
| Affected by recent illness | Strongly (single day) | Moderately (weeks of stress) |
When to use fasting glucose
Fasting plasma glucose is widely available, inexpensive, and familiar to primary care workflows. It is appropriate for initial diabetes screening during an annual physical when the patient can reliably fast overnight.
Fasting values help evaluate dawn phenomenon, assess overnight basal insulin needs in type 1 diabetes, and monitor acute changes during hospitalization or medication adjustments. A repeat test on a separate day is required to confirm a diabetes diagnosis when A1c is not used.
Convert between mg/dL and mmol/L when reading international lab reports or research papers. US labs report mg/dL; Canada, Europe, and Australia typically use mmol/L.
When to use A1c
A1c is the primary monitoring tool for most people with diagnosed diabetes. It does not require fasting, so clinic visits are simpler and patient compliance is higher. The ADA recommends A1c testing at least twice yearly for stable patients and quarterly when therapy changes or targets are not met.
A1c smooths day-to-day glucose variability into one trend number. This makes it better for judging whether long-term control is improving, but worse for catching isolated hypoglycemia or post-meal spikes that self-monitoring reveals.
Estimated average glucose (eAG) converts A1c into the mg/dL scale for patients who think in fingerstick units. The relationship comes from the ADAG study equation: eAG (mg/dL) ≈ 28.7 × A1c − 46.7.
When results disagree
Discordant results happen. Hemoglobin variants (such as sickle cell trait), recent blood loss, transfusion, iron deficiency, chronic kidney disease, and certain ethnic backgrounds can make A1c unreliable. In those cases clinicians rely more on fasting glucose, fructosamine, or continuous glucose monitoring.
A1c can lag behind rapid glucose improvement. After starting intensive therapy, A1c may take six to eight weeks to fully reflect better daily control because older glycated red blood cells still circulate.
Normal fasting glucose with A1c in the prediabetes range suggests postprandial elevation. An oral glucose tolerance test or CGM may clarify whether delayed insulin secretion or high carbohydrate meals drive the mismatch.
Diagnostic standards
The American Diabetes Association accepts either A1c ≥6.5 percent, fasting glucose ≥126 mg/dL, 2-hour OGTT ≥200 mg/dL, or classic hyperglycemia symptoms with random glucose ≥200 mg/dL for diabetes diagnosis. In the absence of symptoms, an abnormal result should be confirmed on a second day.
Prediabetes categories (A1c 5.7 to 6.4 percent or fasting glucose 100 to 125 mg/dL) identify people who benefit from lifestyle intervention. The CDC National Diabetes Prevention Program targets this group with structured weight loss and activity goals.
Neither test alone captures the full glycemic picture for every individual. Many endocrinologists order both at diagnosis and use self-monitoring or CGM for day-to-day adjustments.
Dashed line: Diabetes threshold (126 mg/dL)
Prediabetes starts
100
Diabetes threshold
126
Limitations
Fasting glucose is sensitive to acute stress, poor sleep, caffeine, and infection. A single high reading warrants repeat testing before labeling prediabetes.
A1c is an average and hides variability. Two patients with identical A1c of 7.0 percent may have very different time-in-range profiles on CGM.
These calculators and reference ranges support education only. Diagnosis and treatment decisions belong with a qualified clinician who can interpret labs in clinical context.
Bring both recent fasting glucose and A1c values to appointments when possible. The paired view helps your care team distinguish acute stress effects from sustained glycemic elevation and adjust therapy accordingly.